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Expression of the DNA mismatch repair proteins hMLHI
and hPMS2 in normal human tissues
D Fink, S Nebel, S Aebi, H Zheng, HK Kim, RD Christen and SB Howell
Department of Medicine and the Cancer Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0058, USA
Summary hMLH1 and hPMS2 are part of the DNA mismatch repair complex. Mutations in these genes have been linked to hereditary non-
polyposis colon cancer; they also occur in a variety of sporadic cancers. Western blot analysis and immunohistochemistry demonstrated that
hMLH1 and hPMS2 are widely expressed nuclear proteins with a distribution pattern very similar to that previously described for hMSH2.
These observations showing similar localization of hMLH1 and hPMS2 with hMSH2 are consistent with the biochemical function of these
proteins in DNA mismatch repair.
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Microsatellite instability has been observed in most tumours
arising in patients with hereditary non-polyposis colorectal cancer
(HNPCC) and in many sporadic colon, gastric, endometrial,
ovarian and small-cell lung carcinomas (reviewed by Loeb, 1994).
Microsatellite alterations in such tumours have been postulated to
arise through somatic mutations as a result of loss of the DNA
mismatch repair activity that produces a replication error pheno-
type (Aaltonen et al, 1993). Mutations in any one of four human
DNA mismatch repair genes (hMSH2, hMLH1, hPMS1 and
hPMS2) have been linked to HNPCC (Fishel et al, 1993; Bronner
et al, 1994; Nicolaides et al, 1994). MSH2 and GTBP form a
heterodimer that binds to mismatched bases (Palombo et al, 1995)
and that serves to recruit aheterodimer ofhMLH1 and hPMS2 and
free hPMSl to the complex (Prolla et al, 1994; Li and Modrich,
1995). Recently, Wilson et al (1995) and Leach et al (1996)
demonstrated using immunohistochemistry a particularly promi-
nent staining ofthe hMSH2 protein in the epithelium ofthe diges-
tive tract, extending from the oesophagus to the rectum. Mello et
al (1996) observed using Western blot analysis the highest expres-
sion ofhMSH2 in testis and ovary.
There is as yet no information on the expression ofhMLH1 and
hPMS2 proteins in normal human tissues. Using specific anti-
bodies for hMLHI and hPMS2, we report here that these proteins
are localized in the nucleus and are highly expressed in the epithe-
lium ofthe digestive tract and in the testis and ovary. These obser-
vations showing similar localization of hMLHl and hPMS2 with
hMSH2 emphasize the combined role of these proteins in the
DNA mismatch repair system.
MATERIALS AND METHODS
Cell lines and biopsy specimens
The hMLH1-deficient human colorectal adenocarcinoma cell line
HCT116 was obtained from the American Type Culture
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Collection (ATCC CCL 247); sublines complemented with chro-
mosome 3 (HCTl 16+ch3) and chromosome 2 (HCTl 16+ch2)
were obtained from Drs CR Boland and M Koi. HCT116+ch2
cells lack hMLHI, whereas HCT116+ch3 is complemented by
microcell fusion transfer of chromosome 3 and expresses wild-
type hMLHl (Koi et al, 1994). The cell lines were maintained in
Iscove's modified Dulbecco's medium (Irvine Scientific, Irvine,
CA, USA) supplemented with 2 mM L-glutamine and 10% heat-
inactivated fetal bovine serum. The chromosome-complemented
lines were maintained in medium supplemented with geneticine
(400 jg ml-') (Life Technologies, Gaithersburg, MD, USA).
Frozen tissues were obtained from surgical resections and stored
at-70° C until used.
Western blot analysis
Cells were lysed on ice in 150 mm sodiumchloride containing 5 mm
EDTA, 1% Triton X-100, 10 mm Tris/HCl (pH 7.4), 5 mm DTT,
0.1 mm phenylmethylsulphonyl fluoride and 5 mm c-aminocaproic
acid. After centrifugation, 100 jig of protein was denatured by
boiling in an equal volume of 130 mm Tris/HCl (pH 6.8) containing
20% glycerol, 4.6% sodium dodecyl sulphate (SDS) and 0.02%
bromophenol blue. The proteins were separated using SDS-PAGE
on an 8% gel, followed by electroblotting onto a polyvinylidene
difluoride membrane (Immobilon P; Millipore, Bedford, MA,
USA). hMLH1 was detected using the mouse monoclonal anti-
hMLHI antibody (clone G168-15, PharMingen, San Diego, CA,
USA) at a concentration of 2 jig ml-', followed by horseradish
peroxidase-conjugated anti-mouse antibody (Amersham, Arlington
Heights, IL, USA) and hPMS2 was detected with the rabbit poly-
clonal anti-hPMS2 (E-19, Santa Cruz Biotechnology, Santa Cruz,
CA, USA) at a concentration of 2 jig ml', followed by horseradish
peroxidase-conjugated anti-rabbit antibody (Amersham) and
generation of chemoluminescence by enhanced chemolumines-
cence (ECL) (Amersham).
Immunohistochemistry
Frozen sections were fixed in 10% buffered formalin for 20 min
and then washed in buffer. If needed, endogenous peroxidase
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Figure 1 Western blot analysis with hMLH1 (A) and hPMS2 (B) of protein
extracts from HCT116+ch3 and HCT116+ch2 cells, and normal human testis,
ovary and colon. HCT116+ch2 cells lack hMLH1 expression, whereas
HCT116+ch3 is complemented by chromosome 3 and expresses wild-type
hMLH1. In each lane, 100gg of protein was loaded
activity was quenched with a 10-min incubation in 0.3%
hydrogen peroxide, followed by rinsing in phosphate-buffered
saline (PBS). Non-specific antibody binding was blocked by
incubation for 30 min with 10% goat serum in PBS. Primary
anti-hMLHl antibody or anti-hPMS2 antibody was then incu-
bated with the sections overnight at 4°C at a concentration of 5
,ug ml-1 in 10% goat serum in PBS. The following day, the
sections were washed three times for 5 min in PBS, followed by
incubation with the secondary antibody, prediluted biotinylated
goat anti-rabbit IgG (Dako, Carpinteria, CA, USA), at 15 jg ml-'
in 10% goat serum for 10 min. After two 5-min PBS washes, the
sections were incubated with prediluted streptavidin-conjugated
horseradish peroxidase (Dako) for 10 min. The sections were
then incubated with the chromogen 3-amino-9-ethylcarbazole
(Sigma Chemical, St Louis, MO, USA). Antibody to vimentin
was used as a positive control. The sections were counterstained
with a haematoxylin.
RESULTS
Western blot analysis
The specificity of the hMLHl antibody was examined using
protein extracts from the HCT116+ch2 and HCT116+ch3 cells.
Using immunoblot analysis, the hMLHl antibody reacted with a
single protein ofMr 85 000, consistent with the reported molecular
weight of hMLHl, which was present in lysates from the
HCT116+ch3 cells but not the HCT116+ch2 cells (Figure IA).
The PMS2 antibody detected a single protein ofMr 105 000, which
is consistent with the reported molecular weight ofhPMS2 (Figure
1B). The expression of hMLH1 and hPMS2 was determined by
Western blot analysis of proteins prepared from normal human
tissues from each ofthe major organ systems. The highest expres-
sion of both hMLHI and hPMS2 was found in the testis and the
ovary (Figure 1). Lower levels of expression were observed in
brain, adrenal, heart, stomach, small intestine, skeletal muscle,
liver, kidney, spleen and prostate (data not shown).
Immunohistochemistry
Immunohistochemistry demonstrated that the localization ofboth
hMLHI and hPMS2 was exclusively nuclear in all tissues exam-
ined. Nuclear staining was evident in many different human
tissues, including adrenal cortex, kidney, exocrine pancreas,
prostate and spleen. The expression of hMLHl and hPMS2 was
very prominent in the proliferating epithelia ofthe digestive tract
(Figure 2 A and B). In agreement with the results ofWestern blot
analysis, there was particularly strong staining of both hMLHI
and hPMS2 in the moreprimitive testicular germ cells (Figure 2 E
and F). The nuclei ofthe Sertoli cells and the Leydig cells did not
stain with either antibody. In the ovary, nuclei of the granulosa
cells and ofa subset ofthe stromal cells were stained, whereas the
surface epithelium and the germ cells were non-reactive (Figure 2
C and D).
DISCUSSION
Our results demonstrate that hMLHI and hPMS2 are widely and
concordantly expressed proteins with an exclusively nuclear local-
ization. As described by Wilson et al (1995) and Leach et al (1996)
for hMSH2, the expression ofhMLHl and hPMS2 in the digestive
tract was limited to the cells in the lower part ofthe crypts, antici-
pated to be the replicative fraction, suggesting transcriptional or
translational control of expression analogous to that of other
proteins involved in the DNA replication. However, in other
tissues, nuclear staining was observed in cells that were not clearly
limited to just replicative compartments. Consistent with the
report by Mello et al (1996) for hMSH2, we found the highest
expression of hMLH1 and hPMS2 in the testis and ovary. In the
testis, staining was observed exclusively in the early germ cells,
whereas in the ovary staining was limited to the granulosa and
stromal cells. Because of the importance of transmitting genetic
information without errors, it is not surprising to find the highest
expression of hMLH1 and hPMS2 in the germ cell of the testis.
Baker et al (1995) observed that homozygosity for a null mutation
in the DNA mismatch repair gene PMS2 results in a phenotype
associated with male sterility due to failure in the process of sper-
matogenesis, whereas PMS2-deficient female mice appear fully
fertile.
The results of this study showing a colocalization of hMLHl
and hPMS2 with hMSH2 are consistent with the current under-
standing of the biochemically defined interactions between these
proteins and their function in the DNA mismatch repair system.
Furthermore, the use of immunohistochemistry may offer a rela-
tively rapid method for prescreening tumours for defects in the
expression ofmismatch repair genes.
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Figure 2 Immunohistochemical staining of hMLH1 (A) and hPMS2 (B) in stomach epithelium demonstrating a strong reaction with the nuclei of cells in the
crypts (x 400). Immunohistochemical staining of hMLH1 (C) and hPMS2 (D) in ovary showing staining of nuclei in a subset of the stromal cells (x 200) and the
granulosa cells (C2; x 100) but not in the surface epithelium (Cl; x 400). Immunohistochemical staining of hMLH1 (E) and hPMS2 (F) in testis (x 200). Staining
was observed in the nuclei of the spermatogonia. The nuclei of the Sertoli cells (El) and the Leydig cells (E2) were non-reactive
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